Table 1.
Urinary Creatinine (Cr) Corrected Biomarker Concentrations (ng/g Cr)*
| Biomarker | Group | N | Mean±SD | P-Value |
|---|---|---|---|---|
| BPA | Control | 6 | 1.1±0.4 | |
| H-BPA | 9 | 17.5±11.2 | p<0.01 | |
| Genistein | Control | 6 | 33.9± 20.9 | |
| H-Genistein | 3 | 1286.4±860.3 | p=0.13 | |
| MEPH | Control | 6 | 1.6± 0.9 | |
| MEHP | 3 | 17.2±0.7 | p<0.0001 | |
| MBzP | Control | 6 | 14.4±8.2 | |
| MBzP | 6 | 148.5±119.4 | p<0.05 | |
*
Creatinine corrections were determined using creatinine measurements from the same urine specimens as for the blood biomarker measurements. A T-test for unequal variance was used to determine the statistical significance of the difference in means of the top quintile and control groups.
BPA, bisphenol a; MEHP, mono-ethyl hexyl-phthalate; MBzP, mono-benzyl phthalate